086060 — Genebiotech Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual balance sheet for Genebiotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24,137	14,290	12,790	19,016	21,404
Net Total Accounts Receivable
Net Total Receivables	6,899	10,371	14,302	11,818	14,053
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	45,470	42,175	46,269	49,281	55,836
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12,910	14,900	14,615	14,159	13,924
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	62,085	60,368	64,041	66,017	71,988
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,065	14,139	15,920	14,513	18,364
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	17,042	16,423	18,315	17,712	21,016
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	45,043	43,945	45,726	48,305	50,972
Total Liabilities & Shareholders' Equity	62,085	60,368	64,041	66,017	71,988
Total Common Shares Outstanding